Showing results (1601-1610 of 1,670) with videos related to

Sort By:
Pageof 167
British Journal of Haematology|August 16, 2002
The post-transplant cytogenetic response to interferon is a major determinant of survival after autologous stem cell transplantation for chronic myeloid leukaemia in chronic phaseEduardo Olavarria, Josy Reiffers, Concha Boque, et al.
Military Medicine|July 8, 2022
A Comprehensive, Multidisciplinary Assessment for Knee Osteoarthritis Following Traumatic Unilateral Lower Limb Loss in Service MembersJoseph G Wasser, Brad D Hendershot, Julian C Acasio, et al.
Environment International|December 3, 2014
Protective glove use and hygiene habits modify the associations of specific pesticides with Parkinson's diseaseMelissa Furlong, Caroline M Tanner, Samuel M Goldman, et al.
Haematologica|October 26, 2010
Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised hostHugues de Lavallade, Paula Garland, Takuya Sekine, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 10, 2012
Genetic modification of the association of paraquat and Parkinson's diseaseSamuel M Goldman, Freya Kamel, G Webster Ross, et al.
Msphere|July 14, 2016
ASM Journals Eliminate Impact Factor Information from Journal WebsitesArturo Casadevall, Stefano Bertuzzi, Michael J Buchmeier, et al.
Bone Marrow Transplantation|October 23, 1997
Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationF van Rhee, R M Szydlo, J Hermans, et al.
Communications Medicine|November 26, 2024
Using high-frequency oscillations from brief intraoperative neural recordings to predict the seizure onset zoneBehrang Fazli Besheli, Zhiyi Sha, Jay R Gavvala, et al.
Therapeutic Advances in Medical Oncology|February 13, 2025
Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitorsAhmet Yildirim, Mengting Wei, Yuan Liu, et al.
Blood|August 30, 2002
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemiasOliver G Ottmann, Brian J Druker, Charles L Sawyers, et al.
Pageof 167